These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8186906)

  • 1. [The predictive parameters in the response to almitrine treatment].
    González Ruiz JM; Villamor J; Pino JM; Muñoz J; Lobato SD; Prados C
    Arch Bronconeumol; 1994 Mar; 30(3):141-4. PubMed ID: 8186906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Almitrine bismesylate treatment in chronic respiratory insufficiency].
    González Ruiz JM; Villamor León J; García-Satué JL; Sánchez Agudo L; Calatrava JM; Carreras J
    Rev Clin Esp; 1994 Dec; 194(12):1007-12. PubMed ID: 7863045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease.
    Bardsley PA; Tweney J; Morgan N; Howard P
    Thorax; 1991 Jul; 46(7):493-8. PubMed ID: 1908604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of almitrine bismesylate in chronic obstructive pulmonary disease with CO2 retention].
    Xu FP; Cai YY; Niu SF
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):479-81, 511. PubMed ID: 2128259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency].
    Weitzenblum E; Ehrhart M; Schneider JC; Hirth C; Roegel E
    Bull Eur Physiopathol Respir; 1982; 18(5):765-73. PubMed ID: 6152773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency.
    Bakran I; Vrhovac B; Stangl B; Tabori D; Ivicevic A; Todic V; Kandare F
    Eur J Clin Pharmacol; 1990; 38(3):249-53. PubMed ID: 2187700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
    Voisin C; Howard P; Ansquer JC
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients.
    Weitzenblum E; Schrijen F; Apprill M; Prefaut C; Yernault JC
    Eur Respir J; 1991 Nov; 4(10):1215-22. PubMed ID: 1804669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
    Préfaut C; Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J
    Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease.
    Watanabe S; Kanner RE; Cutillo AG; Menlove RL; Bachand RT; Szalkowski MB; Renzetti AD
    Am Rev Respir Dis; 1989 Nov; 140(5):1269-73. PubMed ID: 2683905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome.
    Jolliet P; Bulpa P; Ritz M; Ricou B; Lopez J; Chevrolet JC
    Crit Care Med; 1997 May; 25(5):786-94. PubMed ID: 9187597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Should arterial gas values be improved in patients with chronic bronchitic respiratory insufficiency? Value of almitrine dimesylate].
    Prefaut C
    Presse Med; 1984 Oct; 13(34):2090-3. PubMed ID: 6149537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration].
    Wuttke R; von Wichert P
    Respiration; 1985; 48(4):285-95. PubMed ID: 3936140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of almitrine on the ventilatory control, breathing pattern and maximal exercise tolerance in hypoxemic patients with chronic obstructive pulmonary disease.
    Ribeiro SA; Jardim JR; Romaldini H; Novo NF; Nery LE
    Braz J Med Biol Res; 1995 Aug; 28(8):859-67. PubMed ID: 8555987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term (6 months) treatment of chronic bronchitis with respiratory insufficiency using almitrine dimesylate. Double-blind study versus placebo].
    Paramelle B; Joubert C; Dain MP
    Presse Med; 1984 Oct; 13(34):2094-8. PubMed ID: 6149538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease.
    Bardsley PA; Howard P; Tang O; Empey D; Harrison B; Peake MD; O'Reilly J; Riordan JF; Wilkinson J; Arnaud F
    Eur Respir J; 1992 Oct; 5(9):1054-61. PubMed ID: 1426214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease.
    Bardsley PA; Howard P; DeBacker W; Vermeire P; Mairesse M; Ledent C; Radermecker M; Bury T; Ansquer J
    Eur Respir J; 1991 Mar; 4(3):308-10. PubMed ID: 1907566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
    Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
    Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease.
    Bell RC; Mullins RC; West LG; Bachand RT; Johanson WG
    Ann Intern Med; 1986 Sep; 105(3):342-6. PubMed ID: 3527011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
    Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
    Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.